Skip to main content

Health Catalyst, Inc.

For the period ended Jun 30, 2025. Filed Aug 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 8, 2025

HCAT$1.44-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations for the and (unaudited)

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

Three Months EndedJune 30,Six Months EndedJune 30,
2025202420252024
Revenue(1):
Technology$52,876$47,635$104,358$94,601
Professional services27,84528,26755,77656,024
Total revenue80,72175,902160,134150,625
Cost of revenue, excluding depreciation and amortization:
Technology18,35216,06735,91731,382
Professional services24,12823,99349,74147,195
Total cost of revenue, excluding depreciation and amortization42,48040,06085,65878,577
Operating expenses:
Sales and marketing13,20612,74527,94431,803
Research and development12,39213,88427,57828,755
General and administrative8,28414,36322,44628,927
Depreciation and amortization12,68410,65725,00421,182
Goodwill impairment28,769—28,769—
Total operating expenses75,33551,649131,741110,667
Loss from operations(37,094)(15,807)(57,265)(38,619)
Interest and other (expense) income, net(3,803)2,361(7,159)4,699
Loss before income taxes(40,897)(13,446)(64,424)(33,920)
Income tax provision8170296183
Net loss$(40,978)$(13,516)$(64,720)$(34,103)
Net loss per share, basic and diluted$(0.59)$(0.23)$(0.94)$(0.58)
Weighted-average shares outstanding used in calculating net loss per share, basic and diluted69,62659,30469,09258,948

(1)Includes amounts attributable to related party transactions. See Note 17 for further details.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.